Hospira irinotecan hydrochloride trihydrate Trihydrate for Injection 40mg/2mL vial

Country: Australia

Bahasa: Inggeris

Sumber: Department of Health (Therapeutic Goods Administration)

Bahan aktif:

irinotecan hydrochloride trihydrate, Quantity: 20 mg/mL

Boleh didapati daripada:

Hospira Australia Pty Ltd

INN (Nama Antarabangsa):

irinotecan hydrochloride trihydrate

Borang farmaseutikal:

Injection, solution

Komposisi:

Excipient Ingredients: lactic acid; sorbitol; water for injections; sodium hydroxide; hydrochloric acid

Laluan pentadbiran:

Intravenous

Unit dalam pakej:

1 x 2 mL vial

Kelas:

Medicine Listed (Export Only)

Jenis preskripsi:

Not scheduled. Not considered by committee

Tanda-tanda terapeutik:

Irinotecan indicated for the treatment of advanced colorectal cancer. -in combination with 5-fluorouracil and folinic acid in patients without prior chemotherapy for advanced cancer -as a single agent in patients who have failed 5-fluorouracil containing treatment regimen.

Ringkasan produk:

Visual Identification: A clear, colourless to pale yellow solution free from visible particulates.; Container Type: Vial; Container Life Time: 3 Years; Container Temperature: Store between 15-30 degrees Celsius

Status kebenaran:

Licence status A

Tarikh kebenaran:

2007-06-20